A small amount of fat does not affect piperaquine exposure in patients with malaria.

A small amount of fat does not affect piperaquine exposure in patients with malaria.

Show other versions (1)

Dihydroartemisinin-piperaquine is a new, highly effective, and well-tolerated combination treatment for uncomplicated falciparum malaria. The lipophilic characteristic of piperaquine suggests that administration together with fat will increase the oral bioavailability of the drug, and this has been...

书目详细资料
Main Authors:	Annerberg, A, Lwin, K, Lindegardh, N, Khrutsawadchai, S, Ashley, E, Day, N, Singhasivanon, P, Tarning, J, White, N, Nosten, F
格式:	Journal article
语言:	English
出版:	2011

相似书籍

A small amount of fat does not affect piperaquine exposure in patients with malaria.
由: Annerberg, A, et al.
出版: (2011)

Population pharmacokinetic assessment of the effect of food on piperaquine bioavailability in patients with uncomplicated malaria.
由: Tarning, J, et al.
出版: (2014)

Comparison of plasma, venous and capillary blood levels of piperaquine in patients with uncomplicated falciparum malaria.
由: Ashley, E, et al.
出版: (2010)

Comparison of plasma, venous and capillary blood levels of piperaquine in patients with uncomplicated falciparum malaria
由: Ashley, E, et al.
出版: (2010)

Pitfalls in estimating piperaquine elimination.
由: Tarning, J, et al.
出版: (2005)

Population pharmacokinetics of piperaquine after two different treatment regimens of dihydroartemisinin piperaquine in patients with acute uncomplicated falciparum malaria in Thailand
由: Tarning, J, et al.
出版: (2007)

Population pharmacokinetics of piperaquine after two different treatment regimens with dihydroartemisinin-piperaquine in patients with Plasmodium falciparum malaria in Thailand.
由: Tarning, J, et al.
出版: (2008)

Randomized, double-blind, placebo-controlled trial of monthly versus bimonthly dihydroartemisinin-piperaquine chemoprevention in adults at high risk of malaria
由: Lwin, K, et al.
出版: (2012)

Randomized, double-blind, placebo-controlled trial of monthly versus bimonthly dihydroartemisinin-piperaquine chemoprevention in adults at high risk of malaria.
由: Lwin, K, et al.
出版: (2012)

Population pharmacokinetics of dihydroartemisinin and piperaquine in pregnant and nonpregnant women with uncomplicated malaria.
由: Tarning, J, et al.
出版: (2012)

Population Pharmacokinetics and Antimalarial Pharmacodynamics of Piperaquine in Patients With Plasmodium vivax Malaria in Thailand.
由: Tarning, J, et al.
出版: (2014)

Population pharmacokinetics and antimalarial pharmacodynamics of piperaquine in patients with plasmodium vivax malaria in Thailand
由: Tarning, J, et al.
出版: (2014)

Dihydroartemisinin-piperaquine versus chloroquine in the treatment of Plasmodium vivax malaria in Thailand: a randomized controlled trial.
由: Phyo, A, et al.
出版: (2011)

Population Pharmacokinetics of Dihydroartemisinin and Piperaquine in Pregnant and Nonpregnant Women with Uncomplicated Malaria
由: Tarning, J, et al.
出版: (2012)

Pharmacokinetics of dihydroartemisinin and piperaquine in pregnant and nonpregnant women with uncomplicated falciparum malaria.
由: Rijken, M, et al.
出版: (2011)

Characterization of an in vivo concentration-effect relationship for piperaquine in malaria chemoprevention.
由: Bergstrand, M, et al.
出版: (2014)

Development and validation of a liquid chromatographic-tandem mass spectrometric method for determination of piperaquine in plasma stable isotope labeled internal standard does not always compensate for matrix effects.
由: Lindegardh, N, et al.
出版: (2008)

Development and validation of an automated solid phase extraction and liquid chromatographic method for the determination of piperaquine in urine.
由: Tarning, J, et al.
出版: (2006)

Population pharmacokinetics and pharmacodynamics of piperaquine in children with uncomplicated falciparum malaria.
由: Tarning, J, et al.
出版: (2012)

Population pharmacokinetics and pharmacodynamics of piperaquine in children with uncomplicated falciparum malaria
由: Tarning, J, et al.
出版: (2012)

Pharmacokinetics of piperaquine in pregnant women in Sudan with uncomplicated Plasmodium falciparum malaria.
由: Adam, I, et al.
出版: (2012)

Efficacy and day 7 plasma piperaquine concentrations in African children treated for uncomplicated malaria with dihydroartemisinin-piperaquine
由: Zongo, I, et al.
出版: (2014)

Pharmacokinetics of piperaquine in pregnant women in Sudan with uncomplicated Plasmodium falciparum malaria
由: Adam, I, et al.
出版: (2012)

A population pharmacokinetic model of piperaquine in pregnant and non-pregnant women with uncomplicated Plasmodium falciparum malaria in Sudan.
由: Hoglund, R, et al.
出版: (2012)

Quantification of the antimalarial piperaquine in plasma.
由: Tarning, J, et al.
出版: (2008)

A RANDOMISED, DOUBLE-BLIND PLACEBO CONTROLLED TRIAL OF TWO DIFFERENT DOSING REGIMENS OF DIHYDROARTEMISININ-PIPERAQUINE FOR INTERMITTENT PREVENTIVE TREATMENT OF ADULTS AT HIGH RISK OF MALARIA IN THAILAND
由: Lwin, K, et al.
出版: (2010)

Pharmacokinetic evaluation and metabolite characterization of the antimalarial piperaquine in the rat
由: Tarning, J, et al.
出版: (2007)

Pharmacokinetics and metabolism of the antimalarial piperaquine after intravenous and oral single doses to the rat.
由: Tarning, J, et al.
出版: (2008)

Electrocardiographic safety evaluation of dihydroartemisinin piperaquine in the treatment of uncomplicated falciparum malaria.
由: Mytton, O, et al.
出版: (2007)

Characterization of human urinary metabolites of the antimalarial piperaquine.
由: Tarning, J, et al.
出版: (2006)

Population pharmacokinetics of lumefantrine in pregnant women treated with artemether-lumefantrine for uncomplicated Plasmodium falciparum malaria.
由: Tarning, J, et al.
出版: (2009)

Efficacy and safety of dihydroartemisinin-piperaquine.
由: Myint, H, et al.
出版: (2007)

Efficacy and day 7 plasma piperaquine concentrations in African children treated for uncomplicated malaria with dihydroartemisinin-piperaquine.
由: Issaka Zongo, et al.
出版: (2014-01-01)

A population pharmacokinetic model of piperaquine in pregnant and non-pregnant women with uncomplicated <it>Plasmodium falciparum</it> malaria in Sudan
由: Hoglund Richard M, et al.
出版: (2012-11-01)

How much fat is necessary to optimize lumefantrine oral bioavailability?
由: Ashley, E, et al.
出版: (2007)

Efficacy and effectiveness of dihydroartemisinin-piperaquine versus artesunate-mefloquine in falciparum malaria: an open-label randomised comparison.
由: Smithuis, F, et al.
出版: (2006)

Population pharmacokinetic properties of Piperaquine in Falciparum Malaria: an individual participant data-level meta-analysis
由: Hoglund, R, et al.
出版: (2017)

Dihydroartemisinin - piperaquine rescue treatment of multidrug-resistant Plasmodium falciparum malaria in pregnancy: a preliminary report
由: Rijken, M, et al.
出版: (2007)

Optimal dosing of dihydroartemisinin-piperaquine for seasonal malaria chemoprevention in young children
由: Chotsiri, P, et al.
出版: (2019)

Dihydroartemisinin-piperaquine versus chloroquine to treat vivax malaria in Afghanistan: an open randomized, non-inferiority, trial.
由: Awab, G, et al.
出版: (2010)